Bio Analysis

3SBio Reports 7.5% YoY Revenue Growth and 25.2% Jump in Profit for 2022

New drugs started to embrace a commercialization wave, and license-out and license-in partnerships geared up. Revenue in 2022 increased by 7.5% year on yea...

 March 22, 2023 | News

New Medium and Feeds System from Thermo Fisher Scientific Boosts CHO Cell Culture Performance

  Thermo Fisher Scientific, a leading biotechnology company, recently provided expert insights into its new media and feed system, Gibco™ Effic...

 March 21, 2023 | News

Robert Walters China Salary Survey 2023: Easing of Epidemic Control: Recruitment Market Stabilises, Data Security and Compliance Talent being Key Recruitment Targets

The demand for mid-to-senior professionals with specific technical skills and background is increasing, such as new energy, integrated circuits, medical de...

 March 02, 2023 | Analysis

Biosimilars Revolutionizing Healthcare in Asia Pacific: A Promising Future Ahead

These products are biologic drugs that are highly similar to an already approved reference biologic drug and are designed to provide cost-effective alterna...

 February 23, 2023 | News

23 LifeScience Companies Changing the World : BioPharma APAC 2023 Outlook

These companies are often involved in the research, development, and production of pharmaceuticals, medical devices, and other health-related products.&nbs...

 January 03, 2023 | News

Looking ahead, it is important that we glean the lessons learned from the pandemic and apply them in our current and future plans to help improve our efforts towards ending the HIV epidemic : Dustin Haines

  Q1. What emerging trends are shaping the future of research in Virology?  This is an extraordinary time in which infectious disease research ...

 October 25, 2022 | Influencers

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announce...

 July 14, 2022 | News

Lessons Learned from COVID-19 Vaccine Trials

    IQVIA Institute releases report on Lessons Learned from COVID-19 Vaccine Trials Solutions for you to dri...

 April 28, 2022 | News

Malaria: One of the leading causes of child deaths, but progress is possible and you can contribute to it

Malaria is a disease that is transmitted by infected mosquitoes. The bite of an infected Anopheles mosquito transmits a parasite that enters the victim...

 March 28, 2022 | News | By Max Roser

Why are Regulations & Guidelines necessary for Drug Development & Manufacturing?

What Led To Drug Regulation? To make sure that a drug product is safe for consumption, it is imperative that the process of drug development and manufactu...

 March 01, 2022 | Opinion

Top 10 Growth Opportunities in the Healthcare & Life Sciences Industry

The post COVID-19 pandemic recovery and other geopolitical events in 2021 has left the healthcare & life sciences industry in a remarkable position to ...

 February 01, 2022 | News

SARS-CoV-2 vaccination creates a strong, persistent T-cell response

Scientists have harnessed T cells to better understand the immune response to mRNA vaccines against SARS-CoV-2, the virus that causes COVID-19. The finding...

 December 24, 2021 | Analysis

Shanghai, industry partners to co-build world-class biopharma industry cluster

The 2021 International Biopharma Industry Week opened in Shanghai on Oct. 11, bringing together industry gurus, research minds, investors, a...

 October 14, 2021 | News

Invitae Highlights the Value of Genetic Testing

- Study finds improved seizure control and positive outcomes in 75 percent of patients with actionable genetic findings that led to clinical management cha...

 September 27, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close